Skip to main content
. 2016 Feb 4;8(4):305–311. doi: 10.4168/aair.2016.8.4.305

Table 6. Effectiveness of montelukast compared to placebo in the non-atopic eczema group.

Changes after taking Montelukast
(Mean±SD)
Changes after taking Placebo drug
(Mean±SD)
P value
SCORAD index 0.7±13.7 -2.7±12.6 0.62
Urine LTE4 (pg/mL) -174.1± 596.5 127.4±562.3 0.18
Urine EDN (ng/mL) -152.0±907.3 -484.7±780.6 0.31

SCORAD, SCORing Atopic Dermatitis; LTE4, leukotriene E4; EDN, eosinophil-derived neurotoxin.